RareResearch.AI
← Back to atlas

R587W

Category 4 — Stable Fold, Function DisruptedConflictingTransmembrane · predictedEditorial
ArginineTryptophan at position 587 · Connecting loop · WFS1 (Wolframin)

Arg→Trp p587 loop AM=0.10 ddg=-0.42 pLDDT=77. ClinVar Conflicting evidence. Atlas mechanism: see structural analysis.

Interactive 3D Structure

Wild-type reference
Wild-type R587 — hydrogen bond to L583
Fullscreen ↗
DynaMut2 mutant · R587W
Mutant W587 — polar contact contact to T590 lost
Fullscreen ↗

Bond changes · DynaMut2 interaction analysis

1 lost0 gained7 preserved
Interaction typeWild-type partnerMutant partnerStatus
Hydrogen bondL583L583Preserved
Hydrogen bondT590T590Preserved
Hydrogen bondS591S591Preserved
Polar contactL583L583Preserved
Polar contactQ584Q584Preserved
Polar contactT590T590Preserved
Polar contactS591S591Preserved
Van der WaalsS591Lost

Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.

Computational Predictions

DynaMut2 ΔΔG
-0.42kcal/mol
Destabilising — mild
AlphaMissense
0.100
LBen
AlphaFold pLDDT
77
model confidence
Schema
Cat 4
Category 4 — Stable Fold, Function Disrupted
ΔΔG confidence: Reduced confidence · Transmembrane
  • transmembrane position; predictor benchmarked on soluble proteins

This variant sits in the transmembrane band. The stability value was computed with a predictor benchmarked on water-soluble proteins. Published benchmarks of ddG predictors on membrane proteins report correlation below 0.4. Treat the magnitude as unreliable and the sign as weak evidence only.

Do not rank this value against a variant from a different region on ΔΔG alone.

Clinical Evidence

ClinVar classificationConflicting classifications of pathogenicity
Review statuscriteria provided, conflicting classifications
Associated conditions(no specific conditions catalogued)
InheritanceConflicting ClinVar classifications.
Population frequency (gnomAD v4)Ultra-rare · AF 0.0087%
cDNA changec.1759C>T
ClinVar accessionVCV001328081
Last evaluated2026/02/04 00:00

Observed at very low frequency in gnomAD.

Classified for1★ unverified submission

ClinVar classifies this variant as Conflicting classifications of pathogenicity for WFS1-related diabetes (autosomal dominant). These are dominant WFS1-related disorders and are clinically distinct from classic recessive Wolfram syndrome. This classification is not a statement about Wolfram syndrome severity.

  • WFS1-related diabetesautosomal dominantsubmitted as: Type 2 diabetes mellitus
  • Submitters conflict on this classification (1★). Treat the conditions above as submitted, not as documented phenotypes.
  • Phenotype scope is interpretation of submitted records. The computed values on this card (AlphaMissense, DynaMut2 ΔΔG, pLDDT) are measurements of the model, not of a patient.
  • Presentation cannot be generalised from neighbouring variants: one nucleotide over can present very differently. Structural similarity supports a mechanistic hypothesis, never a phenotype claim.

Review status: 1★ conflicting classifications. ClinVar "conditions" is the union of all submissions; 0–1★ entries are submitted conditions, not documented phenotypes.

Population frequency
Global (all ancestries)
AF 0.0087% · 141 / 1,614,116 alleles
Homozygotes
0
Highest-frequency population
South Asian · AF 0.054%

Highest in South Asian: AF 0.054% (49 of 91,088 alleles), 6.2x the global figure. The global AF describes the general population, not the at-risk group.

No homozygotes reported in gnomAD v4. For a recessive allele this is expected and is not, on its own, evidence either way.

Ancestry groupAllele freq.AC / ANHom.Carrier est.
South Asian0.054%49 / 91,0880~1 in 930
Middle Eastern · under-sampled0.016%1 / 6,0620
Remaining individuals0.016%10 / 62,5080~1 in 3130
East Asian0.0089%4 / 44,8740~1 in 5610
African / African American0.0067%5 / 75,0660~1 in 7510
European (non-Finnish)0.0058%69 / 1,180,0420~1 in 8550
Admixed American0.0050%3 / 60,0300~1 in 10010

Source: gnomAD r4, retrieved 2026-08-21. Values are allele frequencies. The carrier estimate is derived from the allele frequency (Hardy-Weinberg, ~2·AF) and is an approximation, not a published figure — where a published carrier frequency exists it outranks this column and is cited on the card.

Structural Context

Position analysis: TRP588 (2.4 Å — adjacent existing W!), ALA586 (2.5 Å), THR590 (3.5 Å). Tandem W588-W587 aromatic cluster created. The Atlas's neighbor extraction surfaces this variant's contacts.

Amino-acid chemistry
charge loss + aromatic addition
Position in the protein
Connecting loop

Druggability Assessment

Cat 3/4 — see structural prose. AlphaMissense below threshold (AM under-call class) but mechanism is structurally clear from neighbor analysis. Therapeutic strategy: site-directed at the contacts identified above.

Why this matters

Tandem-aromatic creation in loop.
Therapeutic Strategy Handoff · prediction

Feed this card to Wolfram Intelligence

Download the R587W PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.

Download R587W PDF card ↓Strategies are AI-generated predictions, not validated therapeutics.

UniProt Domain Annotation

Chain1890 · Wolframin